Search for: "MERCK & COMPANY, INC." Results 201 - 220 of 444
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
22 Aug 2012, 6:09 am
Drug companies including Pfizer, Merck & Co. and Bristol Myers-Squibb Co. are squeezed by rising research costs, the weak global economy and pressure from Europe, China and elsewhere to reduce drug prices. [read post]
8 Sep 2010, 7:43 am by Judicial Watch Blog
The Massachusetts company (Aqua Bounty Technologies Inc.) that came up with the idea claims its specially engineered version is identical to the Atlantic salmon except for the speed of its growth. [read post]
24 Nov 2010, 7:00 am
Over 20 million people have taken Fosamax since it was introduced to public markets in 1995 by Merck and Company, Inc. [read post]
16 Mar 2009, 11:20 am
  The report points out that this new analysis was funded by Amylin Pharmaceuticals Inc., the drug company that makes Byetta, and Eli Lilly & Co., which is Amylin's marketing partner for Byetta sales in the U.S. [read post]
12 Mar 2012, 5:41 pm by FDABlog HPM
Merck & Co., Inc., No. 33-av-00001 (D.N.J., Mar. 7, 2012) (Complaint) New England Carpenters Health and Welfare Fund v. [read post]
2 Dec 2009, 4:31 am
Because other countries just decide to pay less – Pfizer’s patent battle against UniLab (Patent Baristas) Moxifloxacin – Venezuela annuls two of Bayer’s patents relating to Moxifloxacin (IP tango) (IP tango) Plavix (Clopidogrel) – India: Indian company, Cadila, bears the brunt of section 3(d) (Spicy IP) Sanctura (Trospium) – US: Allergan files patent infringement suit against Sandoz in response to Para IV challenge (Patent Docs) Taxotere (Docetaxel)… [read post]
1 Dec 2009, 6:46 am
Reynolds, noting that the justices seemed "reluctant to to give the pharmaceutical company Merck & Co. a "statute of limitations" way out of defending against a securities fraud class action. [read post]
1 Apr 2014, 1:44 pm by Tom Lamb
Lastly, as pointed out by this March 26, 2014 MedPage Today article, "Group Wants Testosterone Study Retracted": Several members of the Androgen Study Group have relationships with testosterone drugmakers, including AbbVie, Bayer, and Merck. [read post]
10 Aug 2010, 8:44 pm by Marie Louise
  Highlights this week included: CAFC: Genus-species; doctrine of equivalents; and patentable subject matter: Intervet v Merial Limited (Patently-O) (Holman’s Biotech IP Blog) (IP Spotlight) (IPBiz) (Patent Docs) Angiomax (Bivalirudin) – US: The Medicines Company prevails in patent term extension dispute; USPTO acts quickly to comply with court order (Patent Docs) (Patent Docs) (IPBiz) Skelaxin (Metaxalone) – US: CAFC: Ignoring non-patentable elements while judging… [read post]